Improving pain management for breast cancer survivors
Enhanced Pain Coping in Cancer (EPIC)
This study is looking at a mindfulness program called Mindfulness-Oriented Recovery Enhancement (MORE) to see if it can help breast cancer survivors who are dealing with pain from their treatment, making it easier for them to manage their pain and feel better overall.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10976050 on NIH RePORTER |
What this research studies
This research investigates a mindfulness-based intervention called Mindfulness-Oriented Recovery Enhancement (MORE) to help breast cancer survivors cope with chronic pain, specifically focusing on those experiencing aromatase inhibitor-associated arthralgia. The study aims to assess the effectiveness of MORE in reducing pain and psychological distress through techniques that promote mindfulness, cognitive reappraisal, and savoring experiences. Participants will engage in a randomized controlled trial to evaluate the intervention's impact on their quality of life and pain management. By addressing both physical and emotional aspects of pain, this research seeks to provide a holistic approach to improving the well-being of cancer survivors.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer survivors who are experiencing chronic pain related to aromatase inhibitors.
Not a fit: Patients who are not breast cancer survivors or those not experiencing chronic pain may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective pain management strategies for breast cancer survivors, enhancing their quality of life.
How similar studies have performed: Previous research has shown that mindfulness-based interventions can effectively reduce pain in non-cancer populations, suggesting potential for success in this novel application.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Mao, Jun J — Sloan-Kettering Inst Can Research
- Study coordinator: Mao, Jun J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.